“Inhibition of the TNF-Pathway: Use of Infliximab and Etanercept As Remission-Inducing Agents in Cases of Therapy-Resistant Chronic Inflammatory Disorders”. 2002. Swiss Medical Weekly 132 (2930): 414-14. https://doi.org/10.4414/smw.2002.10031.